APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral TYK2 Inhibitors

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oral TYK2 Inhibitors Industry Research Report 2026

28 December 2025121 pages

Choose your research edition.

Industry ResearchOral TYK2 Inhibitors Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral TYK2 Inhibitors Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Oral TYK2 Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral TYK2 Inhibitors Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral TYK2 Inhibitors Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Oral TYK2 Inhibitors market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oral TYK2 Inhibitors is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oral TYK2 Inhibitors is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oral TYK2 Inhibitors is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oral TYK2 Inhibitors include Bristol Myers Squibb, Galapagos NV, Takeda (Nimbus Therapeutics), Ventyx Biosciences, Changzhou Hengbang Pharmaceutical, Highlightll Pharma, InnoCare and Inventisbio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oral TYK2 Inhibitors market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oral TYK2 Inhibitors Market by Company

Bristol Myers Squibb

Galapagos NV

Takeda (Nimbus Therapeutics)

Ventyx Biosciences

Changzhou Hengbang Pharmaceutical

Highlightll Pharma

InnoCare

Inventisbio

Oral TYK2 Inhibitors Segment by Type

Single-target Inhibitors

Dual-target Inhibitors

Oral TYK2 Inhibitors Segment by Application

Psoriasis

Systemic Lupus Erythematosus

Dermatitis

Arthritis

Others

Oral TYK2 Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral TYK2 Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral TYK2 Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral TYK2 Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oral TYK2 Inhibitors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oral TYK2 Inhibitors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oral TYK2 Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oral TYK2 Inhibitors Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oral TYK2 Inhibitors Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Oral TYK2 Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oral TYK2 Inhibitors Revenue of Manufacturers (2021-2026) Table 9. Global Oral TYK2 Inhibitors Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oral TYK2 Inhibitors Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Oral TYK2 Inhibitors Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oral TYK2 Inhibitors, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oral TYK2 Inhibitors, Product Type & Application Table 14. Global Oral TYK2 Inhibitors Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oral TYK2 Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Bristol Myers Squibb Company Information Table 19. Bristol Myers Squibb Business Overview Table 20. Bristol Myers Squibb Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolio Table 22. Bristol Myers Squibb Recent Developments Table 23. Galapagos NV Company Information Table 24. Galapagos NV Business Overview Table 25. Galapagos NV Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Galapagos NV Oral TYK2 Inhibitors Product Portfolio Table 27. Galapagos NV Recent Developments Table 28. Takeda (Nimbus Therapeutics) Company Information Table 29. Takeda (Nimbus Therapeutics) Business Overview Table 30. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolio Table 32. Takeda (Nimbus Therapeutics) Recent Developments Table 33. Ventyx Biosciences Company Information Table 34. Ventyx Biosciences Business Overview Table 35. Ventyx Biosciences Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolio Table 37. Ventyx Biosciences Recent Developments Table 38. Changzhou Hengbang Pharmaceutical Company Information Table 39. Changzhou Hengbang Pharmaceutical Business Overview Table 40. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolio Table 42. Changzhou Hengbang Pharmaceutical Recent Developments Table 43. Highlightll Pharma Company Information Table 44. Highlightll Pharma Business Overview Table 45. Highlightll Pharma Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Highlightll Pharma Oral TYK2 Inhibitors Product Portfolio Table 47. Highlightll Pharma Recent Developments Table 48. InnoCare Company Information Table 49. InnoCare Business Overview Table 50. InnoCare Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. InnoCare Oral TYK2 Inhibitors Product Portfolio Table 52. InnoCare Recent Developments Table 53. Inventisbio Company Information Table 54. Inventisbio Business Overview Table 55. Inventisbio Oral TYK2 Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Inventisbio Oral TYK2 Inhibitors Product Portfolio Table 57. Inventisbio Recent Developments Table 58. Global Oral TYK2 Inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 59. Global Oral TYK2 Inhibitors Sales by Region (2021-2026) & (K Units) Table 60. Global Oral TYK2 Inhibitors Sales Market Share by Region (2021-2026) Table 61. Global Oral TYK2 Inhibitors Sales by Region (2027-2032) & (K Units) Table 62. Global Oral TYK2 Inhibitors Sales Market Share by Region (2027-2032) Table 63. Global Oral TYK2 Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 64. Global Oral TYK2 Inhibitors Revenue Market Share by Region (2021-2026) Table 65. Global Oral TYK2 Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Oral TYK2 Inhibitors Revenue Market Share by Region (2027-2032) Table 67. North America Oral TYK2 Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. North America Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 69. North America Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 70. North America Oral TYK2 Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 71. North America Oral TYK2 Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 72. Europe Oral TYK2 Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Europe Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 74. Europe Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 75. Europe Oral TYK2 Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 76. Europe Oral TYK2 Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 77. Asia Pacific Oral TYK2 Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 78. Asia Pacific Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 79. Asia Pacific Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 80. Asia Pacific Oral TYK2 Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 81. Asia Pacific Oral TYK2 Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 82. South America Oral TYK2 Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. South America Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 84. South America Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 85. South America Oral TYK2 Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 86. South America Oral TYK2 Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 87. Middle East and Africa Oral TYK2 Inhibitors Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2021-2026) & (K Units) Table 89. Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2027-2032) & (K Units) Table 90. Middle East and Africa Oral TYK2 Inhibitors Revenue by Country (2021-2026) & (US$ Million) Table 91. Middle East and Africa Oral TYK2 Inhibitors Revenue by Country (2027-2032) & (US$ Million) Table 92. Global Oral TYK2 Inhibitors Sales by Type (2021-2026) & (K Units) Table 93. Global Oral TYK2 Inhibitors Sales by Type (2027-2032) & (K Units) Table 94. Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2026) Table 95. Global Oral TYK2 Inhibitors Sales Market Share by Type (2027-2032) Table 96. Global Oral TYK2 Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 97. Global Oral TYK2 Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 98. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2026) Table 99. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2027-2032) Table 100. Global Oral TYK2 Inhibitors Price by Type (2021-2026) & (US$/Unit) Table 101. Global Oral TYK2 Inhibitors Price by Type (2027-2032) & (US$/Unit) Table 102. Global Oral TYK2 Inhibitors Sales by Application (2021-2026) & (K Units) Table 103. Global Oral TYK2 Inhibitors Sales by Application (2027-2032) & (K Units) Table 104. Global Oral TYK2 Inhibitors Sales Market Share by Application (2021-2026) Table 105. Global Oral TYK2 Inhibitors Sales Market Share by Application (2027-2032) Table 106. Global Oral TYK2 Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 107. Global Oral TYK2 Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 108. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2026) Table 109. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2027-2032) Table 110. Global Oral TYK2 Inhibitors Price by Application (2021-2026) & (US$/Unit) Table 111. Global Oral TYK2 Inhibitors Price by Application (2027-2032) & (US$/Unit) Table 112. Key Raw Materials Table 113. Raw Materials Key Suppliers Table 114. Oral TYK2 Inhibitors Distributors List Table 115. Oral TYK2 Inhibitors Customers List Table 116. Oral TYK2 Inhibitors Industry Trends Table 117. Oral TYK2 Inhibitors Industry Drivers Table 118. Oral TYK2 Inhibitors Industry Restraints Table 119. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oral TYK2 Inhibitors Product Image Figure 5. Global Oral TYK2 Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oral TYK2 Inhibitors Market Size (2021-2032) & (US$ Million) Figure 7. Global Oral TYK2 Inhibitors Sales (2021-2032) & (K Units) Figure 8. Global Oral TYK2 Inhibitors Average Price (US$/Unit) & (2021-2032) Figure 9. Single-target Inhibitors Product Image Figure 10. Dual-target Inhibitors Product Image Figure 11. Psoriasis Product Image Figure 12. Systemic Lupus Erythematosus Product Image Figure 13. Dermatitis Product Image Figure 14. Arthritis Product Image Figure 15. Others Product Image Figure 16. Global Oral TYK2 Inhibitors Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Oral TYK2 Inhibitors, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Oral TYK2 Inhibitors Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Oral TYK2 Inhibitors Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Oral TYK2 Inhibitors Sales by Region in 2025 Figure 22. Global Oral TYK2 Inhibitors Revenue by Region in 2025 Figure 23. North America Oral TYK2 Inhibitors Market Size by Country in 2025 Figure 24. North America Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 25. North America Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2032) Figure 26. United States Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Oral TYK2 Inhibitors Market Size by Country in 2025 Figure 30. Europe Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 31. Europe Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2032) Figure 32. Germany Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Oral TYK2 Inhibitors Market Size by Country in 2025 Figure 43. Asia Pacific Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2032) Figure 45. China Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Oral TYK2 Inhibitors Market Size by Country in 2025 Figure 54. South America Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 55. South America Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2032) Figure 56. Brazil Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Oral TYK2 Inhibitors Market Size by Country in 2025 Figure 60. Middle East and Africa Oral TYK2 Inhibitors Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Oral TYK2 Inhibitors Revenue Market Share by Country (2021-2032) Figure 62. Egypt Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Oral TYK2 Inhibitors Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2032) Figure 68. Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2032) Figure 69. Global Oral TYK2 Inhibitors Price (US$/Unit) by Type (2021-2032) Figure 70. Global Oral TYK2 Inhibitors Sales Market Share by Application (2021-2032) Figure 71. Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2032) Figure 72. Global Oral TYK2 Inhibitors Price (US$/Unit) by Application (2021-2032) Figure 73. Oral TYK2 Inhibitors Value Chain Figure 74. Oral TYK2 Inhibitors Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Oral TYK2 Inhibitors Industry Opportunities and Challenges

Scope & coverage.

Types
  • Single-target Inhibitors
  • Dual-target Inhibitors
Applications
  • Psoriasis
  • Systemic Lupus Erythematosus
  • Dermatitis
  • Arthritis
  • Others
Companies covered
  • Bristol Myers Squibb
  • Galapagos NV
  • Takeda (Nimbus Therapeutics)
  • Ventyx Biosciences
  • Changzhou Hengbang Pharmaceutical
  • Highlightll Pharma
  • InnoCare
  • Inventisbio

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oral TYK2 Inhibitors Market Size (2021-2032)
  4. 2.2.2 Global Oral TYK2 Inhibitors Sales (2021-2032)
  5. 2.2.3 Global Oral TYK2 Inhibitors Market Average Price (2021-2032)
  6. 2.3 Oral TYK2 Inhibitors by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Single-target Inhibitors
  9. 2.3.3 Dual-target Inhibitors
  10. 2.4 Oral TYK2 Inhibitors by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Psoriasis
  13. 2.4.3 Systemic Lupus Erythematosus
  14. 2.4.4 Dermatitis
  15. 2.4.5 Arthritis
  16. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oral TYK2 Inhibitors Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oral TYK2 Inhibitors Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Oral TYK2 Inhibitors Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oral TYK2 Inhibitors Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oral TYK2 Inhibitors Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oral TYK2 Inhibitors, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oral TYK2 Inhibitors, Product Type & Application
  8. 3.8 Global Manufacturers of Oral TYK2 Inhibitors, Established Date
  9. 3.9 Global Oral TYK2 Inhibitors Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Bristol Myers Squibb
  2. 4.1.1 Bristol Myers Squibb Company Information
  3. 4.1.2 Bristol Myers Squibb Business Overview
  4. 4.1.3 Bristol Myers Squibb Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Bristol Myers Squibb Oral TYK2 Inhibitors Product Portfolio
  6. 4.1.5 Bristol Myers Squibb Recent Developments
  7. 4.2 Galapagos NV
  8. 4.2.1 Galapagos NV Company Information
  9. 4.2.2 Galapagos NV Business Overview
  10. 4.2.3 Galapagos NV Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Galapagos NV Oral TYK2 Inhibitors Product Portfolio
  12. 4.2.5 Galapagos NV Recent Developments
  13. 4.3 Takeda (Nimbus Therapeutics)
  14. 4.3.1 Takeda (Nimbus Therapeutics) Company Information
  15. 4.3.2 Takeda (Nimbus Therapeutics) Business Overview
  16. 4.3.3 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Takeda (Nimbus Therapeutics) Oral TYK2 Inhibitors Product Portfolio
  18. 4.3.5 Takeda (Nimbus Therapeutics) Recent Developments
  19. 4.4 Ventyx Biosciences
  20. 4.4.1 Ventyx Biosciences Company Information
  21. 4.4.2 Ventyx Biosciences Business Overview
  22. 4.4.3 Ventyx Biosciences Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Ventyx Biosciences Oral TYK2 Inhibitors Product Portfolio
  24. 4.4.5 Ventyx Biosciences Recent Developments
  25. 4.5 Changzhou Hengbang Pharmaceutical
  26. 4.5.1 Changzhou Hengbang Pharmaceutical Company Information
  27. 4.5.2 Changzhou Hengbang Pharmaceutical Business Overview
  28. 4.5.3 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Changzhou Hengbang Pharmaceutical Oral TYK2 Inhibitors Product Portfolio
  30. 4.5.5 Changzhou Hengbang Pharmaceutical Recent Developments
  31. 4.6 Highlightll Pharma
  32. 4.6.1 Highlightll Pharma Company Information
  33. 4.6.2 Highlightll Pharma Business Overview
  34. 4.6.3 Highlightll Pharma Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Highlightll Pharma Oral TYK2 Inhibitors Product Portfolio
  36. 4.6.5 Highlightll Pharma Recent Developments
  37. 4.7 InnoCare
  38. 4.7.1 InnoCare Company Information
  39. 4.7.2 InnoCare Business Overview
  40. 4.7.3 InnoCare Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 InnoCare Oral TYK2 Inhibitors Product Portfolio
  42. 4.7.5 InnoCare Recent Developments
  43. 4.8 Inventisbio
  44. 4.8.1 Inventisbio Company Information
  45. 4.8.2 Inventisbio Business Overview
  46. 4.8.3 Inventisbio Oral TYK2 Inhibitors Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Inventisbio Oral TYK2 Inhibitors Product Portfolio
  48. 4.8.5 Inventisbio Recent Developments
5 Global Oral TYK2 Inhibitors Market Scenario by Region
  1. 5.1 Global Oral TYK2 Inhibitors Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oral TYK2 Inhibitors Sales by Region: 2021-2032
  3. 5.2.1 Global Oral TYK2 Inhibitors Sales by Region: 2021-2026
  4. 5.2.2 Global Oral TYK2 Inhibitors Sales by Region: 2027-2032
  5. 5.3 Global Oral TYK2 Inhibitors Revenue by Region: 2021-2032
  6. 5.3.1 Global Oral TYK2 Inhibitors Revenue by Region: 2021-2026
  7. 5.3.2 Global Oral TYK2 Inhibitors Revenue by Region: 2027-2032
  8. 5.4 North America Oral TYK2 Inhibitors Market Facts & Figures by Country
  9. 5.4.1 North America Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oral TYK2 Inhibitors Sales by Country (2021-2032)
  11. 5.4.3 North America Oral TYK2 Inhibitors Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Oral TYK2 Inhibitors Market Facts & Figures by Country
  16. 5.5.1 Europe Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Oral TYK2 Inhibitors Sales by Country (2021-2032)
  18. 5.5.3 Europe Oral TYK2 Inhibitors Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Oral TYK2 Inhibitors Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Oral TYK2 Inhibitors Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Oral TYK2 Inhibitors Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Oral TYK2 Inhibitors Market Facts & Figures by Country
  41. 5.7.1 South America Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Oral TYK2 Inhibitors Sales by Country (2021-2032)
  43. 5.7.3 South America Oral TYK2 Inhibitors Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Oral TYK2 Inhibitors Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Oral TYK2 Inhibitors Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Oral TYK2 Inhibitors Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Oral TYK2 Inhibitors Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Oral TYK2 Inhibitors Sales by Type (2021-2032)
  2. 6.1.1 Global Oral TYK2 Inhibitors Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Oral TYK2 Inhibitors Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oral TYK2 Inhibitors Revenue by Type (2021-2032)
  5. 6.2.1 Global Oral TYK2 Inhibitors Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oral TYK2 Inhibitors Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oral TYK2 Inhibitors Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oral TYK2 Inhibitors Sales by Application (2021-2032)
  2. 7.1.1 Global Oral TYK2 Inhibitors Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Oral TYK2 Inhibitors Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oral TYK2 Inhibitors Revenue by Application (2021-2032)
  5. 7.2.1 Global Oral TYK2 Inhibitors Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oral TYK2 Inhibitors Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oral TYK2 Inhibitors Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oral TYK2 Inhibitors Value Chain Analysis
  2. 8.1.1 Oral TYK2 Inhibitors Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oral TYK2 Inhibitors Production Mode & Process
  5. 8.2 Oral TYK2 Inhibitors Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oral TYK2 Inhibitors Distributors
  8. 8.2.3 Oral TYK2 Inhibitors Customers
9 Global Oral TYK2 Inhibitors Analyzing Market Dynamics
  1. 9.1 Oral TYK2 Inhibitors Industry Trends
  2. 9.2 Oral TYK2 Inhibitors Industry Drivers
  3. 9.3 Oral TYK2 Inhibitors Industry Opportunities and Challenges
  4. 9.4 Oral TYK2 Inhibitors Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst